India · Delayed Price · Currency is INR Nuvoco Vistas Corporation Earnings Call Transcripts
Fiscal Year 2026
-
Record annual volumes and EBITDA achieved, with strong Q4 performance and premiumization gains. Rising input costs and supply chain challenges are being managed through price hikes, efficiency initiatives, and strategic CapEx, while industry demand is expected to grow 7%-9% in FY 2027.
-
Q3 FY 2026 saw record cement volumes and a 50% EBITDA increase year-over-year, driven by strong demand recovery, premiumization, and cost efficiencies. Expansion projects and disciplined capital management position the company for double-digit growth and margin improvement.
-
Q2 FY 2026 saw a 62% YoY EBITDA increase to INR 371 crore, driven by premiumization and operational efficiency, despite monsoon and GST transition headwinds. Expansion projects in East and West are on track, with demand and volume growth expected to accelerate in H2.
-
Record Q1 performance with 6% volume and 9% revenue growth, highest-ever Q1 EBITDA, and strong premiumization. Vadraj Cement acquisition expands Western presence, with CapEx and financing plans in place. Demand outlook remains positive, targeting 7%-10% growth.
Fiscal Year 2025
-
Achieved record cement sales and revenue growth in Q4 FY 2025, with robust cost savings and premiumization. Vadraj Cement acquisition will expand capacity, funded with minimal net debt increase. Demand outlook remains strong, supported by government capex and favorable market conditions.
-
Q3 FY 2025 saw 16% YoY volume growth and improved cost efficiencies, though realizations were impacted by weak prices until December. The Vadraj Cement acquisition will expand capacity and market presence, with integration and NCLT approval as key risks.
-
Revenue and EBITDA declined YoY due to weak demand and pricing pressure, but cost efficiencies and premiumization supported margins. Net debt reduced YoY, with further deleveraging and high single-digit H2 volume growth targeted. Demand recovery hinges on government project execution.